- Home
- INVH vs TEVA Comparison
INVH vs TEVA Comparison
Compare INVH & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVH
- TEVA
- Stock Information
- Founded
- INVH 2012
- TEVA 1901
- Country
- INVH United States
- TEVA Israel
- Employees
- INVH N/A
- TEVA N/A
- Industry
- INVH Real Estate
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- INVH Finance
- TEVA Health Care
- Exchange
- INVH Nasdaq
- TEVA Nasdaq
- Market Cap
- INVH 20.9B
- TEVA 23.7B
- IPO Year
- INVH 2017
- TEVA N/A
- Fundamental
- Price
- INVH $31.34
- TEVA $21.92
- Analyst Decision
- INVH Buy
- TEVA Buy
- Analyst Count
- INVH 16
- TEVA 7
- Target Price
- INVH $38.69
- TEVA $22.43
- AVG Volume (30 Days)
- INVH 3.5M
- TEVA 10.1M
- Earning Date
- INVH 02-26-2025
- TEVA 01-29-2025
- Dividend Yield
- INVH 3.70%
- TEVA N/A
- EPS Growth
- INVH N/A
- TEVA N/A
- EPS
- INVH 0.72
- TEVA N/A
- Revenue
- INVH $2,554,563,000.00
- TEVA $16,772,000,000.00
- Revenue This Year
- INVH N/A
- TEVA $5.74
- Revenue Next Year
- INVH $4.44
- TEVA $4.46
- P/E Ratio
- INVH $43.63
- TEVA N/A
- Revenue Growth
- INVH 7.65
- TEVA 9.81
- 52 Week Low
- INVH $30.13
- TEVA $10.86
- 52 Week High
- INVH $37.80
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- INVH 44.98
- TEVA 61.44
- Support Level
- INVH $30.33
- TEVA $20.15
- Resistance Level
- INVH $31.72
- TEVA $22.10
- Average True Range (ATR)
- INVH 0.62
- TEVA 0.62
- MACD
- INVH 0.03
- TEVA -0.13
- Stochastic Oscillator
- INVH 53.32
- TEVA 66.79
About INVH Invitation Homes Inc.
Invitation Homes owns a portfolio of nearly 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 16 target markets that feature high employment and household formation growth with almost 70% of the portfolio in the Western U.S. and Florida; 15 of the 16 markets featuring average rents lower than homeownership costs.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.